AstraZeneca Covid 19 Vaccine: Researchers have claimed that the Covid-19 vaccine of British-Swedish pharma giant AstraZeneca, developed in collaboration with Oxford University, has been found to have an increased risk of immune thrombocytopenia and thrombosis (VITT). This is a serious condition in which a blood clot forms. In fact, at the peak of the Covid pandemic in 2021, VITT has emerged as a new disease after the adenovirus vector-based Oxford-AstraZeneca vaccine sold as Covishield in India and Vaxjavria in Europe. Dangerous blood autoantibodies to platelet factor 4 (PF4) have been…
Read MoreAstraZeneca Covid 19 vaccine Another deadly blood clotting disorder Revealed in Flinders University research
